Jackson Tai Elected to Lilly Board of Directors

PR Newswire/Les Echos/ 
Jackson Tai Elected to Lilly Board of Directors 
INDIANAPOLIS, Oct. 22, 2013 -- The Board of Directors of Eli Lilly and Company
(NYSE:LLY) has elected Jackson Tai as a new member, effective November 1, 2013.
As a member of Lilly's board, Mr. Tai will serve on the Audit and Finance
Tai, 63, serves as a non-executive director of The Bank of China Limited,
Singapore Airlines, NYSE Euronext, MasterCard Incorporated, and Royal Philips
NV. From 2002 to 2007, he was vice chairman and chief executive officer of both
DBS Group Holdings and DBS Bank, one of the largest financial services groups 
in Asia. Tai joined DBS as Chief Financial Officer in July 1999 and was 
president and chief operating officer of DBS from January 2001 to June 2002. 
"I am delighted to welcome Jack Tai to the Lilly board," said John C.
Lechleiter, Ph.D., Lilly chairman, president and chief executive officer. "Mr.
Tai brings to the Lilly board extensive experience in international business 
and finance, including serving as the CEO of a major multinational financial
institution and as a board member of several leading global companies. Having
lived and worked in Japan and Singapore for almost 15 years, Jack has a deep
understanding of the Asia-Pacific region that will be particularly helpful as
our business in Asia continues to grow." 
Prior to his appointment at DBS, Tai was an investment banker for 25 years with
J.P. Morgan & Co. Incorporated. Among his assignments at J.P. Morgan, Tai was
senior regional officer and head of investment banking for Asia Pacific, based
in Tokyo; founder and global head of real estate investment banking, based in
New York; senior regional officer and head of investment banking for the 
Western United States, based in San Francisco; and executive director of J.P. 
Morgan Securities' Japanese business, based in Tokyo. 
Tai serves as a trustee of Rensselaer Polytechnic Institute and a director of
the Committee of 100. He is a member of the Harvard China Advisory Group and 
the Harvard Business School Asia-Pacific Advisory Board. He is also a director 
of privately-held Russell Reynolds Associates and Brookstone, Inc. 
Tai received his MBA in 1974 from Harvard University where he was a recipient 
of a Council for Opportunity in Graduate Management Education fellowship. He
graduated f rom Rensselaer Polytechnic Institute in 1972 with a Bachelors of
Science degree in Management. 
About Lilly
Lilly, a leading innovation-driven corporation, is developing a growing
portfolio of pharmaceutical products by applying the latest research from its
own worldwide laboratories and from collaborations with eminent scientific
organizations. Headquartered in Indianapolis, Ind., Lilly provides answers -
through medicines and information - for some of the world's most urgent medical
needs. Additional information about Lilly is available at www.lilly.com. C-LLY 
(Logo: http://photos.prnewswire.com/prnh/20031219/LLYLOGO)  
Refer to: (317) 433-9899 - Edward Sagebiel

SOURCE Eli Lilly and Company 
The content and accuracy of news releases published on this site and/or 
distributed by PR Newswire or its partners are the sole responsibility of the 
originating company or organisation. Whilst every effort is made to ensure the 
accuracy of our services, such releases are not actively monitored or reviewed 
by PR Newswire or its partners and under no circumstances shall PR Newswire or 
its partners be liable for any loss or damage resulting from the use of such 
information. All information should be checked prior to publication. 
-0- Oct/23/2013 06:24 GMT
Press spacebar to pause and continue. Press esc to stop.